Jeito Capital

Biotechnology · Venture Capital
$104.9Mraised by its portfolio in 12 months
9open roles in its portfolio
23investments
6exits

Overview

Jeito Capital is a biotech venture fund built around a patient benefit approach to investing. It finances breakthrough medical innovation in private biopharmaceutical companies across Europe and the United States, supporting them from early development to late clinical stages. The firm was founded in Paris in 2019 by Rafaele Tordjman, a physician and long-time life sciences investor.

Investor profile

Venture capital
Investments
23
11 of them startups
Hiring now
3
9 open roles
Rounds in 12 months
3
$104.9M raised
Exits
6
Focusshare of its companies
Health Care 93%Biotechnology 33%
Where its companies are
United States 17%United Kingdom 4%Germany 4%Switzerland 4%France 4%
Stage of its companies
Series A 67%Series B 33%
Hiring fastestroles opened in 30 days
Sources: its portfolio page, read Nov 3; 3 rounds in the press that name it

People

Sabine Dandiguian Moumdjian
Directeur Général
Rafaele Tordjman
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris France
HQ
Select Page
10-50 est. staff
37 rue de la Victoire, 75009 PARIS
company site